பிரிட்டிஷ் இதய சமூகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரிட்டிஷ் இதய சமூகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரிட்டிஷ் இதய சமூகம் Today - Breaking & Trending Today

Role of Echocardiography in Endocarditis

Endocarditis is a life-threatening disease that involves inflammation of the endocardium, heart valve, and vascular intima. ....

United Kingdom , Emily Henderson , Heart British Cardiac Society , Image Credit , Infective Endocarditis , Echocardiographic Imaging , New Imaging , British Cardiac Society , ஒன்றுபட்டது கிஂக்டம் , எமிலி ஹென்டர்சன் , இதயம் பிரிட்டிஷ் இதய சமூகம் , படம் கடன் , புதியது இமேஜிங் , பிரிட்டிஷ் இதய சமூகம் ,

Simulation Model based on Pooled Phase 3 Data Demonstrating

Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21
May 15, 2021 12:00 ET
| Source:
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc.
Ann Arbor, Michigan, UNITED STATES
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction in 10-year cardiovascular event risk compared with statins alone (p ....

United States , United Kingdom , City Of , Kaitlyn Brosco , Gunn Laura , Daiichi Sankyo Europe , Nicholls Stephen , Laurah Gunn , Honorary Research , University Of North Carolina At Charlotte , American College Of Cardiology , Department Of Public Health Sciences , School Of Public Health , Lipid Management Company , Exchange Commission , Imperial College London , European Medicines Agency , Heart British Cardiac Society , School Of Data Science , Second Manifestations , Cholesterol Treatment Trialist , American College , Annual Scientific Session , Cardiovascular Benefits , Bempedoic Acid , Patients With Established Cardiovascular Disease ,

Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet's Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21

Share:
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction in 10-year cardiovascular event risk compared with statins alone (p ....

United States , United Kingdom , City Of , Kaitlyn Brosco , Gunn Laura , Daiichi Sankyo Europe , Nicholls Stephen , Laurah Gunn , Honorary Research , University Of North Carolina At Charlotte , American College Of Cardiology , Department Of Public Health Sciences , School Of Public Health , Lipid Management Company , Exchange Commission , Imperial College London , European Medicines Agency , Heart British Cardiac Society , School Of Data Science , Second Manifestations , Cholesterol Treatment Trialist , American College , Annual Scientific Session , Cardiovascular Benefits , Bempedoic Acid , Patients With Established Cardiovascular Disease ,

Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet's ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , United Kingdom , City Of , Kaitlyn Brosco , Gunn Laura , Laurah Gunn , Nicholls Stephen , Honorary Research , University Of North Carolina At Charlotte , American College Of Cardiology , Department Of Public Health Sciences , School Of Public Health , Lipid Management Company , Exchange Commission , Imperial College London , European Medicines Agency , Heart British Cardiac Society , School Of Data Science , Second Manifestations , Cholesterol Treatment Trialist , American College , Annual Scientific Session , Cardiovascular Benefits , Bempedoic Acid , Patients With Established Cardiovascular Disease , Associate Professor ,